Financials
- Market Capitalization 7 M
- Employee 10
- Founded 2003
- CEO N/A
- Website www.ensysce.com
- Headquarter Delaware, United States
- FIGI BBG00JFF4174
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.12
Relación precio/flujo de caja
0.26
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4859 | CURX Curanex Pharmaceuticals Inc - Common Stock | 4.64 USD | -1.49% | +2109.52% | +2220.00% | +22.11% | 7.28 M USD | ||
| 4862 | ALZN Alzamend Neuro, Inc. - Common Stock | 1.45 USD | -7.05% | -6.45% | +7.41% | -40.82% | 6.95 M USD | ||
| 4873 | IMRN Immuron Limited - American Depositary Shares | 1.14 USD | 0.00% | +5.56% | +1.79% | -36.67% | 6.67 M USD | ||
| 4875 | LIMN Liminatus Pharma, Inc. - Class A Common Stock | 4.62 USD | -10.29% | +3200.00% | +4100.00% | +40.85% | 6.21 M USD |